Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes
Clinical trial NCT02134717 · TERMINATED
Trial details
- NCT number
- NCT02134717
- Sponsor
- Kevin F. Gibson
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.